Search Results - "Peres, Igor T"

Public hospitalizations for stroke in Brazil from 2009 to 2016 by Dantas, Leila F, Marchesi, Janaina F, Peres, Igor T, Hamacher, Silvio, Bozza, Fernando A, Quintano Neira, Ricardo A

“…Stroke is the third major cause of death in the world and the second in Brazil. The purpose of this work was to assess the stroke-related hospitalization,…”
Get full text

App-based symptom tracking to optimize SARS-CoV-2 testing strategy using machine learning by Dantas, Leila F, Peres, Igor T, Bastos, Leonardo S L, Marchesi, Janaina F, de Souza, Guilherme F G, Gelli, João Gabriel M, Baião, Fernanda A, Maçaira, Paula, Hamacher, Silvio, Bozza, Fernando A

“…Tests are scarce resources, especially in low and middle-income countries, and the optimization of testing programs during a pandemic is critical for the…”
Get full text

What we talk about when we talk about COVID-19 vaccination campaign impact: a narrative review by Hastenreiter Filho, Horácio N, Peres, Igor T, Maddalena, Lucas G, Baião, Fernanda A, Ranzani, Otavio T, Hamacher, Silvio, Maçaira, Paula M, Bozza, Fernando A

“…The lack of precise definitions and terminological consensus about the impact studies of COVID-19 vaccination leads to confusing statements from the scientific…”
Get full text

Optimization in inventory-routing problem with planned transshipment: A case study in the retail industry by Peres, Igor T., Repolho, Hugo M., Martinelli, Rafael, Monteiro, Nathália J.

“…Logistics is a science widely recognized as a value-added component for organizations and their products and services as it optimizes the use of resources,…”
Get full text

Vaccine effectiveness of ChAdOx1 nCoV-19 against COVID-19 in a socially vulnerable community in Rio de Janeiro, Brazil: a test-negative design study by Ranzani, Otavio T., Silva, Amanda A.B., Peres, Igor T., Antunes, Bianca B.P., Gonzaga-da-Silva, Thiago W., Soranz, Daniel R., Cerbino-Neto, José, Hamacher, Silvio, Bozza, Fernando A.

“…To estimate vaccine effectiveness after the first and second dose of ChAdOx1 nCoV-19 against symptomatic COVID-19 and infection in a socially vulnerable…”
Get full text